EUVIMEDEUVIMED entdecken
Crossref

Injectable Cisplatin-Loaded Biodegradable Poly(anhydride-ester) for Treating Head and Neck Cancer: Preclinical Studies

Christine Warwar Damouny, Narmeen Matta, Muhammad Abdel Haq, Abraham Nyska, Peter Siman, Abraham J Domb iD

ACS Biomaterials Science & Engineering · 2026

DOI: 10.1021/acsbiomaterials.5c01699 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Biomaterials Science & Engineering, 2026. Verfasst von Christine Warwar Damouny und 5 weiteren Autor:innen. Beteiligte Einrichtung: Intragel Therapeutics LTD., Wadi El Haj 13, PO Box 1252, Nazareth Industrial Area, Nazareth 17111, Israel. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Cisplatin, Antineoplastic Agents, Polyanhydrides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The first-line treatment for unresectable HPV-negative squamous cell carcinoma of head and neck (SCCHN) patients involves weekly or triweekly systemic cisplatin chemotherapy concurrently with radiotherapy. Cisplatin induces severe systemic toxicity that prevents a portion of patients from receiving the standard of care while redirecting them to less effective alternatives. This means worsening prognosis and overall survival (OS). A single-dose long-acting cisplatin limits toxicity. This is an injectable, biodegradable polyanhydride derived from sebacic acid (SA) and ricinoleic acid (RA) investigated as a targeted small-volume, high-payload carrier to improve safety and enhance efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Head and Neck NeoplasmsCisplatinAntineoplastic AgentsPolyanhydridesFemaleAnimalsRatsSwineInjectionsMiceMaleDrug Evaluation, PreclinicalHumans

Stichwörter der Autor:innen

FaDu xenograftP(SARA)biodegradablecisplatinhead and neck cancerinjectableintratumorallong-actingpolyanhydride

Substanzen

CisplatinAntineoplastic AgentsPolyanhydrides

Autor:innen und Institutionen

  • Intragel Therapeutics LTD., Wadi El Haj 13, PO Box 1252, Nazareth Industrial Area, Nazareth 17111, Israel.
  • School of Pharmacy - Faculty of Medicine, Hadassah Medical Center, Ein Kerem, The Hebrew University of Jerusalem, Jerusalem 91120, Israel.
  • Jerusalem College of Technology (JCT), Jerusalem 9372115, Israel.
  • Tel Aviv University and Consultant in Toxicologic Pathology, Timrat 18740, Israel.

ORCID-Profile: Abraham J Domb

Zitieren

APA

Warwar Damouny, C., Matta, N., Abdel Haq, M., Nyska, A., Siman, P., & Domb, A. J. (2026). Injectable Cisplatin-Loaded Biodegradable Poly(anhydride-ester) for Treating Head and Neck Cancer: Preclinical Studies. ACS Biomaterials Science & Engineering. https://doi.org/10.1021/acsbiomaterials.5c01699

Vancouver

Warwar Damouny C, Matta N, Abdel Haq M, Nyska A, Siman P, Domb AJ. Injectable Cisplatin-Loaded Biodegradable Poly(anhydride-ester) for Treating Head and Neck Cancer: Preclinical Studies. ACS Biomaterials Science & Engineering. 2026. doi:10.1021/acsbiomaterials.5c01699

BibTeX
@article{WarwarDamouny2026,
  author = {Warwar Damouny, Christine and Matta, Narmeen and Abdel Haq, Muhammad and Nyska, Abraham and Siman, Peter and Domb, Abraham J},
  title = {Injectable Cisplatin-Loaded Biodegradable Poly(anhydride-ester) for Treating Head and Neck Cancer: Preclinical Studies},
  journal = {ACS Biomaterials Science & Engineering},
  year = {2026},
  doi = {10.1021/acsbiomaterials.5c01699}
}
Kostenlos starten →